Sat, Sep 20, 2014, 2:44 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

SciClone Pharmaceuticals, Inc. Message Board

a65232389 2 posts  |  Last Activity: Aug 19, 2014 7:16 PM Member since: Sep 24, 2009
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    Recent insider purchase

    by shelm081061 Aug 19, 2014 10:37 AM
    a65232389 a65232389 Aug 19, 2014 7:16 PM Flag

    Tough to see where there could me more cost cutting. R&D was at $800K for the quarter and G&A seems almost reasonable. If any of the new things move forward and there is some clinical or regulatory work SCLN has to do this figure will go up. Company does have tons of overhead. Business is all in China so there is a China CEO and a China CFO along with a U.S. CEO and U.S. CFO.

  • Reply to

    Recent insider purchase

    by shelm081061 Aug 19, 2014 10:37 AM
    a65232389 a65232389 Aug 19, 2014 3:12 PM Flag

    Totally free shares. Company gave him 12,500 shares and he 'forfeits' 4,197 of them to cover the taxes on the grant. Guess who pays the IRS? The company. For Blobel and other executive officers this is great. Tax-free shares sure beat the old options grants.

SCLN
6.98-0.11(-1.55%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.